Related references
Note: Only part of the references are listed.Symptom management: An important part of cancer care
Laura K. Shoemaker et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2011)
Inhibition of Atrogin-1/MAFbx Expression by Adenovirus-Delivered Small Hairpin RNAs Attenuates Muscle Atrophy in Fasting Mice
Haolong Cong et al.
HUMAN GENE THERAPY (2011)
An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
Gary Gintant
PHARMACOLOGY & THERAPEUTICS (2011)
Guidelines for the welfare and use of animals in cancer research
P. Workman et al.
BRITISH JOURNAL OF CANCER (2010)
A Pharmacologically Active Monoclonal Antibody against the Human Melanocortin-4 Receptor: Effectiveness After Peripheral and Central Administration
Jean-Christophe Peter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Update on melanocortin interventions for cachexia: Progress toward clinical application
Mark Daniel DeBoer
NUTRITION (2010)
Hypothalamic mechanisms in cachexia
Aaron J. Grossberg et al.
PHYSIOLOGY & BEHAVIOR (2010)
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2010)
Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice
Philipp Weyermann et al.
PLOS ONE (2009)
Cardiac cachexia: A systematic overview
Stephan von Haehling et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists
Chen Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
Shu-Feng Zhou
CURRENT DRUG METABOLISM (2008)
Depression and cancer: recent data on clinical issues, research challenges and treatment approaches
Michel Reich
CURRENT OPINION IN ONCOLOGY (2008)
Discovery of 1-{2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methyl-phenyl}-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia
Chen Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Anorexia in chronic obstructive pulmonary disease - Association to cachexia and hormonal derangement
Friedrich Koehler et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases
Jennifer M. Sacheck et al.
FASEB JOURNAL (2007)
A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in Pomc null mice
Y. C. Loraine Tung et al.
ENDOCRINOLOGY (2006)
Energy homeostasis and cachexia in chronic kidney disease
Robert H. Mak et al.
PEDIATRIC NEPHROLOGY (2006)
Therapy Insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease
Mark D. DeBoer et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice
JR Nicholson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Interactions between the melanocortin system and the hypothalamo-pituitary-thyroid axis
NM Martin et al.
PEPTIDES (2006)
MCL0042: A nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity
S Chaki et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
The use of melanocortin antagonists in cachexia of chronic disease
JM Scarlett et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist
S Markison et al.
ENDOCRINOLOGY (2005)
Therapy Insight: cancer anorexia-cachexia syndrome - when all you can eat is yourself
A Laviano et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones
RA Frost et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2005)
In vitro methods to study chemically-induced hepatotoxicity:: A literature review
D Farkas et al.
CURRENT DRUG METABOLISM (2005)
Therapy Insight: cancer anorexia-cachexia syndrome - when all you can eat is yourself
A Laviano et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Meal patterns and foraging in melanocortin receptor knockout mice
CH Vaughan et al.
PHYSIOLOGY & BEHAVIOR (2005)
Identification of 2-{2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluoro-phenyl}-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model
TJ Vos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides
EJB Ramos et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Validated assays for human cytochrome P450 activities
RL Walsky et al.
DRUG METABOLISM AND DISPOSITION (2004)
The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade
K Starowicz et al.
BRAIN RESEARCH (2003)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Differential role of melanocortin receptor subtypes in cachexia
DL Marks et al.
ENDOCRINOLOGY (2003)
Cachexia in liver cirrhosis
M Plauth et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2002)
Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model
M Papp et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1
P Puigserver et al.
MOLECULAR CELL (2001)
Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog
C Lu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2001)
Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals
CJ Small et al.
DIABETES (2001)
A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors
L Ste Marie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
